| scholarly article | Q13442814 |
| P50 | author | Arthur J. Moss | Q49030014 |
| Wojciech Zareba | Q63963026 | ||
| Ilan Goldenberg | Q89825693 | ||
| P2093 | author name string | Andrew W Dick | |
| Barry J Maron | |||
| P2860 | cites work | Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death | Q24294267 |
| Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 | Q28145423 | ||
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 | ||
| Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. | Q33145274 | ||
| Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration | Q33148719 | ||
| Long QT Syndrome. | Q33148863 | ||
| Implantable cardioverter defibrillator in high-risk long QT syndrome patients | Q33148945 | ||
| Modulating effects of age and gender on the clinical course of long QT syndrome by genotype | Q33149140 | ||
| Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome | Q33151232 | ||
| Hypertrophic cardiomyopathy: an important cause of sudden death | Q33172595 | ||
| A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias | Q33175452 | ||
| Hypertrophic cardiomyopathy: a systematic review | Q34117625 | ||
| Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
| Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence | Q35209707 | ||
| Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. | Q35367410 | ||
| Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure | Q40508209 | ||
| Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants | Q40595299 | ||
| Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). | Q43540414 | ||
| Clinical course of hypertrophic cardiomyopathy in a regional United States cohort | Q43565120 | ||
| Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy | Q43852488 | ||
| ??? | Q28207558 | ||
| Clinical implications for affected parents and siblings of probands with long-QT syndrome. | Q52058026 | ||
| Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems. | Q52211600 | ||
| Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. | Q52884067 | ||
| Epidemiology of Hypertrophic Cardiomyopathy–Related Death | Q57841451 | ||
| Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest | Q57841613 | ||
| Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy | Q58819293 | ||
| The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations | Q71040238 | ||
| Images in cardiovascular medicine. Extreme left ventricular hypertrophy | Q71807787 | ||
| Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy | Q73893854 | ||
| The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial | Q74645906 | ||
| Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy | Q81765966 | ||
| P433 | issue | 4 Suppl | |
| P921 | main subject | defibrillator | Q1450682 |
| P304 | page(s) | 67-83 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Annals of Noninvasive Electrocardiology | Q2354750 |
| P1476 | title | Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias | |
| P478 | volume | 10 |
| Q37844148 | Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies |
| Q33819489 | Economic evaluation of strategies to reduce sudden cardiac death in young athletes |
| Q56977271 | Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon |
| Q36860996 | Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. |
| Q35742313 | Inherited arrhythmic disorders: long QT and Brugada syndromes |
| Q84943739 | Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction |
| Q37193184 | Primary prevention of sudden cardiac death using implantable cardioverter defibrillators |
| Q46114842 | Refractory long QT syndrome and the role of left cardiac sympathetic denervation |
| Q37766175 | Sudden death in hypertrophic cardiomyopathy |
| Q38163484 | The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations |
Search more.